Congratulations to Prof. Susan Gasser who is being awarded an honorary degree (Doctor honoris causa) from the Charles University in Prague. Susan Gasser is the director of the Friedrich Miescher Institute in Basel and was a group leader at the ISREC Institute between 1986 and 2001.

Prof. Susan Gasser

© photograph Karls-Universität

The laying of the foundation stone for the AGORA – Cancer Center took place this morning on the hospital premises. Three representatives of the cantonal government, Pierre Yves Maillard, Anne-Catherine Lyon and Pascal Broulis, as well as Prof. Pierre-François Leyvraz, director of the CHUV and Prof. George Coukos, head of the oncology department, were present at the ceremony.

PRESS RELEASE

The ISREC Foundation is pleased to announce the laying of the foundation stone for its flagship project, the “AGORA – Cancer Center”, which will dedicate itself to translational cancer research.

The building, located in the vicinity of the CHUV, will be inaugurated in early 2018. The AGORA project, initiated by the ISREC Foundation, is the result of a partnership with the CHUV, the University of Lausanne, the EPFL, the Ludwig Institute for Cancer Research and the Geneva University Hospitals. AGORA strives to become a center of excellence that will attract top specialists in the area of cancer research.

Watch the development of the construction site

Within the scope of the “Rencontres arts et sciences” organized by the CHUV, Professor George Coukos, head of the oncology department at the CHUV, will give a lecture entitled “Protocols: At the Interface between Artistic Experimentation and Medical Research”.

The talk will be followed by a concert offered by the Haute Ecole de Musique de Lausanne.

Program

CHUV

HEMU

19th edition of this race, organized by Team Girard.

Since 1998, the Club Team Girard, including owners, riders and fans of vintage motorcycles, organizes a yearly hill climb event for old-timers and donates part of the profits to the ISREC Foundation.

For more information

The ISREC Foundation supports 6 students within the scope of the “Summer Research Program for Undergraduate Students” – EPFL School of Life Sciences, and 6 students in the “Summer Undergraduate Research Program” – Faculty of Biology and Medicine, University of Lausanne.

During these eight weeks of hands-on training, the selected young biologists or physicians are given the chance to discover the world of research for the very first time; a rewarding experience and the opportunity to establish new contacts on an international level. At the end of the program, the students will present their work during a mini symposium held at the EPFL campus.

More information : SRP (EPFL) and SUR (UNIL)

6th edition of this fund-raising event organized by volunteers in memory of their friend Agostino who died of cancer.

Each year, approximately fifty volunteers contribute to the success of various tournaments and activities, enabling the organizers to make a significant donation to our foundation’s projects.
For more information

Horizons of Cancer Biology and Therapy

Following on from the ISREC Symposia in 2011 on ‘Hallmarks of Cancer’, and 2014 on ‘Metastasis’, the next ISREC Symposium, to be held in Lausanne in September 2016, will focus on broad themes – ‘Horizons – in Cancer Biology and Therapy’. This symposium will also symbolize the new multi–institutional Swiss Cancer Center Lausanne (SCCL) inauguration.

More information

EPFL scientists have developed an animal model for breast cancer that faithfully captures the disease. Tested on human breast tissue, this the most clinically realistic model for breast cancer to date.

More information

Tissue section from an intraductal xenograft’s hormone receptor-positive breast cancer, stained for fibrillar collagen networks © G. Sflomos/EPFL

EPFL scientists have developed an animal model for breast cancer that faithfully captures the disease. Tested on human breast tissue, this the most clinically realistic model for breast cancer to date.

More information

Tissue section from an intraductal xenograft’s hormone receptor-positive breast cancer, stained for fibrillar collagen networks © G. Sflomos/EPFL